Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Bronchopulmonary aspergillosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Opelconazole

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Chronic graft versus host disease

Not recruiting

InvestigationalNo placebo

Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Acute graft versus host disease in intestine

Not recruiting

InvestigationalNo placebo

Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Faecal Microbiota, Pooled

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Embolism venous

Not recruiting

Registered drugNo placebo

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abelacimab

Contact Research Centre

Find therapies in clinical trials near you – page 20

390 trials match your criteria

Hidradenitis

Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Soft tissue sarcoma

Study of PM14 Alone and with Radiotherapy for Patients with Advanced Soft Tissue Sarcomas and Other Solid Tumors

Bladder cancer recurrent+1

Study on Mycobacterium Bovis Bacillus Calmette-Guérin for High-risk Non-muscle Invasive Bladder Cancer Patients

Neurodermatitis

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Bronchopulmonary aspergillosis

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Hormone receptor positive HER2 negative breast cancer

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Non-small cell lung cancer

Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Breast cancer+1

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Chronic graft versus host disease

Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

Acute graft versus host disease in intestine

Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

Squamous cell carcinoma of head and neck

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Embolism venous

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.